Discontinued — last reported Q1 '21

Non-Current Assets

Equipment Installment Plan Receivables (Non-Current), Net

Royalty Pharma Equipment Installment Plan Receivables (Non-Current), Net increased by 2.1% to $16.54B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.0%, from $15.03B to $16.54B. Over 5 years (FY 2020 to FY 2025), Equipment Installment Plan Receivables (Non-Current), Net shows an upward trend with a 5.6% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2019
Last reportedQ1 2021
Metric ID: equipment_installment_plan_receivables_noncurrent

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$12.93B$14.01B$13.72B$13.47B$13.42B$14.29B$13.49B$13.66B$13.27B$13.23B$14.09B$13.47B$13.89B$14.97B$15.13B$15.03B$15.13B$15.76B$16.21B$16.54B
QoQ Change—+8.4%-2.1%-1.8%-0.3%+6.4%-5.6%+1.3%-2.9%-0.3%+6.5%-4.4%+3.2%+7.8%+1.1%-0.6%+0.7%+4.2%+2.8%+2.1%
YoY Change————+3.8%+2.0%-1.6%+1.4%-1.2%-7.4%+4.4%-1.4%+4.7%+13.1%+7.4%+11.6%+9.0%+5.3%+7.1%+10.0%
Range$12.93B – $16.54B
CAGR+5.3%
Avg YoY Growth+4.3%
Median YoY Growth+4.6%
Current Streak4 quarters growth

Frequently Asked Questions

What is Royalty Pharma's equipment installment plan receivables (non-current), net?
Royalty Pharma (RPRX) reported equipment installment plan receivables (non-current), net of $16.54B in Q1 2026.
How has Royalty Pharma's equipment installment plan receivables (non-current), net changed year-over-year?
Royalty Pharma's equipment installment plan receivables (non-current), net increased by 10.0% year-over-year, from $15.03B to $16.54B.
What is the long-term trend for Royalty Pharma's equipment installment plan receivables (non-current), net?
Over 5 years (2020 to 2025), Royalty Pharma's equipment installment plan receivables (non-current), net has grown at a 5.6% compound annual growth rate (CAGR), from $12.37B to $16.21B.